相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。An environmentally benign multi-component reaction: Highly regioselective synthesis of functionalized 2-(diarylphosphoryl)-1,2-dihydro-pyridine derivatives
Kun Li et al.
GREEN SYNTHESIS AND CATALYSIS (2022)
SCF FBXW17 E3 ubiquitin ligase regulates FBXL19 stability and cell migration
Su Dong et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2021)
Establishment of high-throughput screening HTRF assay for identification small molecule inhibitors of Skp2-Cks1
Kaizhao Hu et al.
SCIENTIFIC REPORTS (2021)
Emerging Roles of SKP2 in Cancer Drug Resistance
Ting Wu et al.
CELLS (2021)
The SCF Complex Is Essential to Maintain Genome and Chromosome Stability
Laura L. Thompson et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Aminocatalytic stereoselective synthesis of (E)-α-naphthyl enals via cross-coupling-like reaction of 1-bromo-2-naphthols with enals
Xixi Song et al.
GREEN SYNTHESIS AND CATALYSIS (2021)
Targeting the Ubiquitin-Proteasome System for Cancer Therapeutics by Small-Molecule Inhibitors
Gabriel LaPlante et al.
CANCERS (2021)
Therapeutic targeting of the E3 ubiquitin ligase SKP2 in T-ALL
Sonia Rodriguez et al.
LEUKEMIA (2020)
Drug Development Targeting the Ubiquitin-Proteasome System (UPS) for the Treatment of Human Cancers
Xiaonan Zhang et al.
CANCERS (2020)
The FBXL family of F-box proteins: variations on a theme
Bethany Mason et al.
OPEN BIOLOGY (2020)
Ubiquitin-proteasome system (UPS) as a target for anticancer treatment
Jinyoung Park et al.
ARCHIVES OF PHARMACAL RESEARCH (2020)
F-box proteins and cancer: an update from functional and regulatory mechanism to therapeutic clinical prospects
Dinesh Singh Tekcham et al.
THERANOSTICS (2020)
Emerging drug development technologies targeting ubiquitination for cancer therapeutics
Gianluca Veggiani et al.
PHARMACOLOGY & THERAPEUTICS (2019)
The role of SCF ubiquitin-ligase complex at the beginning of life
Jiayan Xie et al.
REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY (2019)
Cellular quality control by the ubiquitin-proteasome system and autophagy
Christian Pohl et al.
SCIENCE (2019)
Therapy for Pulmonary Arterial Hypertension in Adults Update of the CHEST Guideline and Expert Panel Report
James R. Klinger et al.
CHEST (2019)
Deubiquitylating enzymes and drug discovery: emerging opportunities
Jeanine A. Harrigan et al.
NATURE REVIEWS DRUG DISCOVERY (2018)
Activity-based E3 ligase profiling uncovers an E3 ligase with esterification activity
Kuan-Chuan Pao et al.
NATURE (2018)
A Structure-Based Strategy for Engineering Selective Ubiquitin Variant Inhibitors of Skp1-Cul1-F-Box Ubiquitin Ligases
Maryna Gorelik et al.
STRUCTURE (2018)
Structure and Function of the 26S Proteasome
Jared A. M. Bard et al.
ANNUAL REVIEW OF BIOCHEMISTRY, VOL 87 (2018)
Ubiquitin ligases in oncogenic transformation and cancer therapy
Daniela Senft et al.
NATURE REVIEWS CANCER (2018)
Composition and Regulation of the Cellular Repertoire of SCF Ubiquitin Ligases
Justin M. Reitsma et al.
CELL (2017)
Developing structure-activity relationships from an HTS hit for inhibition of the Cks1-Skp2 protein-protein interaction
Rajinder Singh et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2015)
Deubiquitinase inhibition as a cancer therapeutic strategy
Padraig D'Arcy et al.
PHARMACOLOGY & THERAPEUTICS (2015)
SCF ubiquitin ligase-targeted therapies
Jeffrey R. Skaar et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
Identification of small molecule inhibitors of p27Kip1 ubiquitination by high-throughput screening
Li-Ching Ooi et al.
CANCER SCIENCE (2013)
Pharmacological Inactivation of Skp2 SCF Ubiquitin Ligase Restricts Cancer Stem Cell Traits and Cancer Progression
Chia-Hsin Chan et al.
CELL (2013)
High-Throughput Screening AlphaScreen Assay for Identification of Small-Molecule Inhibitors of Ubiquitin E3 Ligase SCFSkp2-Cks1
Dana Ungermannova et al.
JOURNAL OF BIOMOLECULAR SCREENING (2013)
p27Kip1 as a prognostic factor in breast cancer: a systematic review and meta-analysis
Xiaoxiang Guan et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2010)
Aberrant expression of Cks1 and Cks2 contributes to prostate tumorigenesis by promoting proliferation and inhibiting programmed cell death
Yongsheng Lan et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Skp2 suppresses p53-dependent apoptosis by inhibiting p300
Mayumi Kitagawa et al.
MOLECULAR CELL (2008)
Structure-activity studies on diphenylpyrazine derivatives: A novel class of prostacyclin receptor agonists
Tetsuo Asaki et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2007)
Structural basis of the Cks1-dependent recognition of p27Kip1 by the SCFSkp2 ubipuitin ligase
B Hao et al.
MOLECULAR CELL (2005)
Degradation of p57Kip2 mediated by SCFSkp2 -: dependent ubiquitylation
T Kamura et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Structure of the Cul1-Rbx1-Skp1-F boxSkp2 SCF ubiquitin ligase complex
N Zheng et al.
NATURE (2002)
The cell-cycle regulatory protein Cks1 is required for SCFSkp2-mediated ubiquitinylation of p27
D Ganoth et al.
NATURE CELL BIOLOGY (2001)
Targeted disruption of Skp2 results in accumulation of cyclin E and p27Kip1, polyploidy and centrosome overduplication
K Nakayama et al.
EMBO JOURNAL (2000)
The F-box protein family
Edward T. Kipreos et al.
GENOME BIOLOGY (2000)
分享论文
